SEC Form 4 · accession 0001144204-16-076472
CASI Pharmaceuticals, Inc. · CASI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cynthia W. Hu
Officer — COO
Period of report
Jan 19, 2016
Accepted (ET)
Jan 21, 2016 · 2:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000895051
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 19, 2016 | P | 400 | $0.7478 | A | 1,385 | D | |
| Common Stock | Jan 19, 2016 | P | 400 | $0.7497 | A | 1,785 | D | |
| Common Stock | Jan 19, 2016 | P | 4,163 | $0.719 | A | 5,948 | D | |
| Common Stock | Jan 19, 2016 | P | 11,837 | $0.7197 | A | 17,785 | D | |
| Common Stock | holding | — | — | — | 74,982 | I | HELD BY SPOUSE |
Table II — derivative securities
No Table II lines on this filing.